---
figid: PMC8000754__cancers-13-01235-g004
figlink: pmc/articles/PMC8000754/figure/cancers-13-01235-f004/
number: Figure 4
caption: Proteasome inhibitors and metabolic pathways. Enhancement of glucose and
  glutamine metabolism is a hallmark of cancer cells, including multiple myeloma (MM).
  Targeting deranged cellular metabolism at various levels enhances the cytotoxicity
  of proteasome inhibitors in MM. Inhibition of the glucose transporter GLUT1 (STF-31)
  or the non-pharmacological inhibition of HIF1α and LDHA enzymes result in synergistic
  cell death with proteasome inhibitors (PI). The tricarboxylic acid (TCA) cycle enzyme
  IDH2 is synthetic lethal to PI through NAMPT/SIRT3/IDH2 pathway (AGI-6780, FK866).
  Degradation of glutamine can be targeted with Asparaginase (ASNase) or Glutaminase
  inhibitor (CB-832), affecting glutamate-dependent metabolites of TCA cycle. The
  cellular energy sensor AMPK is synthetically lethal to PI. OXPHOS inhibition by
  the mitochondrial protease ClpP (ONC201) leads to cellular stress and upregulation
  of transcriptional factor ATF4.
pmcid: PMC8000754
papertitle: The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations
  in Multiple Myeloma.
reftext: Tina Paradzik, et al. Cancers (Basel). 2021 Mar;13(6):1235.
pmc_ranked_result_index: '3188'
pathway_score: 0.9633801
filename: cancers-13-01235-g004.jpg
figtitle: Proteasome inhibitors and metabolic pathways
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8000754__cancers-13-01235-g004.html
  '@type': Dataset
  description: Proteasome inhibitors and metabolic pathways. Enhancement of glucose
    and glutamine metabolism is a hallmark of cancer cells, including multiple myeloma
    (MM). Targeting deranged cellular metabolism at various levels enhances the cytotoxicity
    of proteasome inhibitors in MM. Inhibition of the glucose transporter GLUT1 (STF-31)
    or the non-pharmacological inhibition of HIF1α and LDHA enzymes result in synergistic
    cell death with proteasome inhibitors (PI). The tricarboxylic acid (TCA) cycle
    enzyme IDH2 is synthetic lethal to PI through NAMPT/SIRT3/IDH2 pathway (AGI-6780,
    FK866). Degradation of glutamine can be targeted with Asparaginase (ASNase) or
    Glutaminase inhibitor (CB-832), affecting glutamate-dependent metabolites of TCA
    cycle. The cellular energy sensor AMPK is synthetically lethal to PI. OXPHOS inhibition
    by the mitochondrial protease ClpP (ONC201) leads to cellular stress and upregulation
    of transcriptional factor ATF4.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A1
  - HIF1A
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - WDTC1
  - LDHA
  - TFPI
  - ATF4
  - CLPP
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - NAMPT
  - IDH2
  - SIRT3
  - GLS
  - SGCG
  - dorsomorphin
  - ADP
  - Pyruvate
  - Lactate
  - Acetyl-CoA
  - AGI6780
  - Isocitric acid
  - NAD
  - NAMPT E FK866
  - NMM
  - NAM
  - Ketoglutaric acid
  - TCA
  - Glu
  - NH
genes:
- word: GLUT1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: HIF1A
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: EPI
  symbol: EPI
  source: hgnc_alias_symbol
  hgnc_symbol: TFPI
  entrez: '7035'
- word: ATF4
  symbol: ATF4
  source: hgnc_symbol
  hgnc_symbol: ATF4
  entrez: '468'
- word: CIpP
  symbol: CLPP
  source: hgnc_symbol
  hgnc_symbol: CLPP
  entrez: '8192'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: IDH2
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: SIRT3
  symbol: SIRT3
  source: hgnc_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: GLS1
  symbol: GLS1
  source: hgnc_alias_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: types
  symbol: TYPE
  source: hgnc_alias_symbol
  hgnc_symbol: SGCG
  entrez: '6445'
chemicals:
- word: dorsomorphin
  source: MESH
  identifier: C516138
- word: ADP
  source: MESH
  identifier: D000244
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Lactate
  source: MESH
  identifier: D019344
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: AGI6780
  source: MESH
  identifier: C581155
- word: Isocitric acid
  source: MESH
  identifier: C034219
- word: NAD
  source: MESH
  identifier: D009243
- word: NAMPT E FK866
  source: MESH
  identifier: C480543
- word: NMM
  source: MESH
  identifier: C060847
- word: NAM
  source: MESH
  identifier: C051625
- word: Ketoglutaric acid
  source: MESH
  identifier: D007656
- word: TCA
  source: MESH
  identifier: C000589078
- word: Glu
  source: MESH
  identifier: C094686
- word: NH
  source: MESH
  identifier: D000641
diseases: []
---
